APA (7th ed.) Citation

Hu, W., Liu, Y., Li, J., Wang, Y., Sun, X., Hua, M., . . . Hui, B. (2024). Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells. Toxicology in vitro, 99, 105867. https://doi.org/10.1016/j.tiv.2024.105867

Chicago Style (17th ed.) Citation

Hu, Wei-Bin, Yi-Ting Liu, Jing Li, Ying Wang, Xuan-Zi Sun, Ming-Yu Hua, Xue-Ting Liu, and Bei-Na Hui. "Pristimerin Exhibits Anti-cancer Activity by Inducing ER Stress and AKT/GSK3β Pathway Through Increasing Intracellular ROS Production in Human Esophageal Cancer Cells." Toxicology in Vitro 99 (2024): 105867. https://doi.org/10.1016/j.tiv.2024.105867.

MLA (9th ed.) Citation

Hu, Wei-Bin, et al. "Pristimerin Exhibits Anti-cancer Activity by Inducing ER Stress and AKT/GSK3β Pathway Through Increasing Intracellular ROS Production in Human Esophageal Cancer Cells." Toxicology in Vitro, vol. 99, 2024, p. 105867, https://doi.org/10.1016/j.tiv.2024.105867.